• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WOLVERINE CORONARY CUTTING BALLOON MONORAIL; CATHETER, PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA), CUTTING/SCORING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WOLVERINE CORONARY CUTTING BALLOON MONORAIL; CATHETER, PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA), CUTTING/SCORING Back to Search Results
Model Number 3851
Device Problems Break (1069); Difficult to Remove (1528)
Patient Problem Device Embedded In Tissue or Plaque (3165)
Event Date 07/24/2020
Event Type  Injury  
Event Description
It was reported that the shaft was fractured and remained inside patient.The target lesion was located in the severely calcified left anterior descending artery (lad).A 10mmx2.50mm wolverine coronary cutting balloon was selected for use.During procedure, the balloon crossed the lesion normally, but it got stuck in the proximal lad and failed to be withdrawn.Subsequently, the shaft fractured after several attempts to remove and the body of the balloon remained in the lesion.Then, two emerge balloons, two nc emerge balloons, two synergy stents and a guidezilla were used which adhered the fragment in the vascular wall.The procedure was completed with the device fragment remaining in the patient's body.The patient was sent to the icu and in stable condition.No further complications reported.
 
Event Description
It was reported that the shaft was fractured and remained inside patient.The target lesion was located in the severely calcified left anterior descending artery (lad).A 10mmx2.50mm wolverine coronary cutting balloon was selected for use.During procedure, the balloon crossed the lesion normally, but it got stuck in the proximal lad and failed to be withdrawn.Subsequently, the shaft fractured after several attempts to remove and the body of the balloon remained in the lesion.Then, two emerge balloons, two nc emerge balloons, two synergy stents and a guidezilla were used which adhered the fragment in the vascular wall.The procedure was completed with the device fragment remaining in the patient's body.The patient was sent to the icu and in stable condition.No further complications reported.
 
Manufacturer Narrative
Cine/media was returned to the manufacturer: the device was not returned for analysis.Cine images were provided by the customer and were analyzed as part of the product analysis by the investigator.The event description was consistent with the cines provided as balloon separation was observed.The efforts to stabilize this challenging situation were also observed through the implantation of stents which resulted in achieving a flow patent through the area, where the dislodged balloon was localized.An incomplete balloon expansion which was most likely induced by the presence of lesion calcium.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WOLVERINE CORONARY CUTTING BALLOON MONORAIL
Type of Device
CATHETER, PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA), CUTTING/SCORING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key10365636
MDR Text Key201671463
Report Number2134265-2020-10064
Device Sequence Number1
Product Code NWX
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 09/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/14/2022
Device Model Number3851
Device Catalogue Number3851
Device Lot Number0025447636
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 07/24/2020
Initial Date FDA Received08/04/2020
Supplement Dates Manufacturer Received09/02/2020
Supplement Dates FDA Received09/28/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age71 YR
-
-